Free Trial
OTCMKTS:RGBP

Regen BioPharma (RGBP) Stock Price, News & Analysis

Regen BioPharma logo

About Regen BioPharma Stock (OTCMKTS:RGBP)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.17 million shs
Average Volume
15.23 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regen BioPharma, Inc. is a biotechnology company focused on developing therapies in immunotherapy and regenerative medicine. Its work includes research into approaches for treating cancer and blood disorders.

The company has described investigational programs including dCellVax, a dendritic-cell cancer immunotherapy, and HemaXellerate I, a cell-based therapy intended for aplastic anemia. These are development-stage candidates, not approved treatments.

Regen BioPharma also conducts research into NR2F6, a protein it has explored as a potential target for cancer immunotherapy. The company’s activities are centered on drug and therapy development rather than the sale of established medicines.

AI Generated. May Contain Errors.

Receive RGBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RGBP Stock News Headlines

Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Regen BioPharma Delays Quarterly SEC Filing
Regen Biopharma Signs Convertible Note Agreement
See More Headlines

RGBP Stock Analysis - Frequently Asked Questions

Shares of Regen BioPharma split on Thursday, June 20th 2024.The 3-1 split was announced on Thursday, June 20th 2024. The newly minted shares were issued to shareholders after the market closes on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Regen BioPharma investors own include Trans Global Group (TGGI), Enzolytics (ENZC), Vapor (HCMC), PHI Group (PHIL), 88 Energy (EEENF), ADMA Biologics (ADMA) and BioLineRx (BLRX).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:RGBP
CIK
1589150
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:RGBP) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners